Tech Startup IPOs Better with Big Blue Patents

The Strategic Business Planning Company has long championed an aggressive  approach by startup companies that centers on obtaining a patent(s) on a new product/service at or near the time of market entry to offer unique value and competitive protection.  Very young companies need funding.  Venture capitalists are a major source of funding and, according to a study by the University of California Berkeley Law School, “many investors place a premium on patents when making investment decisions.  In fact, 67% of firms surveyed indicated that the existence of patents were an important factor in their investment decisions… proving that it doesn’t matter what industry you are in a significant percentage of VCs place a premium of patents when making investment decisions.”  (“Why Patents Matter for Job Creation and Economic Growth,” Gene Quinn, IP Watchdog) [For additional confirmation, see Shark Tank]

• The first patent application increases a company’s employment growth over the next five years by 36%.  The effect on sales growth – a 51% increase – is even larger.
• Approval of a patent application increases a start-up’s probability of securing VC funding  by 53% over companies without patents.
• Patents more than double the likelihood that a start-up is eventually listed on a stock exchange.

  To make your market introduction positioning even stronger, buy some patents from IBM before your IPO as described in this blog post from iam-media.com:  http://www.iam-media.com/Blog/Detail.aspx?g=e5b4517b-6c86-4932-8451-6bb110c6b011.  Banks, in addition to venture capitalists, look favorably on tech startups that have a patent portfolio from Big Blue which has sold 15,000 patents since 1991.

IBM has been the leader in annual patent procurement for years and years.  But, even in Big Blue, not all patents can be commercialized and many other patents are not consistent with its marketing strategies.  For these reasons and, it turns out, for tax benefits, the company puts many patents on the market to supplement its licensing royalties.